Vertex Pharmaceuticals Inc (FRA:VX1)
€ 444.25 -4.35 (-0.97%) Market Cap: 112.76 Bil Enterprise Value: 107.67 Bil PE Ratio: 30.10 PB Ratio: 6.47 GF Score: 87/100

Vertex Pharmaceuticals Incorporated at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 11:00 AM GMT
Release Date Price: €447.85 (+1.14%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VRTX.OQ - Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated at Morgan Stanley Global Healthcare Conference
Sep 14, 2026 / 11:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Good morning, everybody. I'm Terrence Flynn, Morgan Stanley's U.S. Biopharma analyst, pleased to be kicking off our 24th annual healthcare conference here in New York City. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. I'm very pleased to be kicking off the conference this morning with Vertex Pharmaceuticals. Joining me is Reshma Kewalramani, who is the company's CEO and President.

Thank you so much, Reshma. It's great to see you this morning bright and early.

-------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot